Content about Overactive bladder

January 25, 2013

Merck: FDA approves Oxytrol for Women, creating overactive bladder category in OTC

Merck on Friday announced the Food and Drug Administration has approved the switch of Oxytrol for Women (oxybutynin transdermal system, 3.9 mg/day) from prescription-only to nonprescription, creating a new category — overactive bladder in women — in the OTC area.

November 29, 2012

FDA approves Mylan overactive bladder drug

The Food and Drug Administration approved a new generic drug made by Mylan for urinary disorders, the company said Thursday.

November 15, 2012

FDA panel advises against Merck's Oxytrol patch Rx-to-OTC switch application

The Food and Drug Administration's Nonprescription Drugs Advisory Committee on Friday voted against Merck's application to switch its Oxytrol patch from prescription-only to over the counter, citing concerns over use of therapy for an overactive bladder in women without a doctor's intervention.

November 12, 2012

Reports: CVS Caremark drops 17 drugs from formulary

The PBM division of CVS Caremark is hoping to get patients to use lower-cost drugs for certain conditions by removing higher-cost drugs from its formulary, according to published reports.

October 22, 2012

Astellas bladder drug made available in U.S.

The U.S. subsidiary of Japanese drug maker Astellas Pharma has made a drug for overactive bladder available in U.S. pharmacies, the company said.

September 6, 2012

Kalorama reports several new OTC categories under consideration by FDA

Kalorama Information on Thursday reported that a number of Rx-to-OTC switch applications currently are under review by the Food and Drug Administration across several new-to-self-care categories, including overactive bladder, bacterial infections, cholesterol and high blood pressure.

September 4, 2012

FDA's Nonprescription Drugs Advisory Committee to meet on Oxytrol Rx-to-OTC switch

According to a Food and Drug Administration post Friday, the FDA's Nonprescription Drugs Advisory Committee will be meeting Nov. 9 regarding the partial switch application from prescription to over the counter of Oxytrol (oxybutynin transdermal system), as submitted by MSD Consumer.

August 3, 2012

Drug for overactive bladder effective in patients who haven't responded well to earlier therapy, study finds

A drug made by Pfizer and used to treat overactive bladder was effective in reducing leakage of urine in patients with the disorder, according to the results of a post-approval clinical study.

June 28, 2012

FDA approves overactive bladder drug made by Astellas

The Food and Drug Administration has approved a new drug for treating overactive bladder made by Astellas Pharma, the agency said Thursday.

April 6, 2012

FDA advisory committee recommends approval for Astellas overactive bladder drug

A panel of Food and Drug Administration experts has recommended approval for a drug made by Astellas Pharma for overactive bladder.

April 4, 2012

Patents covering Sanctura XR invalid, court rules

A court has ruled that patents covering a drug used for overactive bladder are invalid, a company looking to launch a generic version of the drug said.

December 9, 2011

FDA approves Antares Pharma's overactive bladder drug

The Food and Drug Administration has approved a topical gel made by Antares Pharma for overactive bladder.

December 6, 2011

Pfizer's Toviaz safe, effective in treating overactive bladder in elderly patients

A drug made by Pfizer appears to work in treating overactive bladder in elderly patients, according to results of a clinical trial released Monday.

September 23, 2010

Warner Chilcott acquires rights to Enablex

Drug maker Warner Chilcott will buy the U.S. rights to a treatment for overactive bladder...